Discovery and structural investigation of Varicella-Zoster virus gE-neutralizing antibodies isolated from a convalescent patient

Lulu Wang; Zihan Jia; Xiaohan Ye; Chunxiao Chen; Baofa Sun; Xiangshuai Zhao; Ruiqi Zhang; Ying Li; Wenya Wang; Zixian Sun; Lushuai Zhou; Zhiyu Ni; Nan Zhang; Yu Guo

doi:10.1093/procel/pwaf051

Protein Cell ›› 2025, Vol. 16 ›› Issue (12) : 1054 -1059. DOI: 10.1093/procel/pwaf051

LETTER

Discovery and structural investigation of Varicella-Zoster virus gE-neutralizing antibodies isolated from a convalescent patient

Author information +

History +

PDF (13242KB)

Cite this article

Download citation ▾

Lulu Wang, Zihan Jia, Xiaohan Ye, Chunxiao Chen, Baofa Sun, Xiangshuai Zhao, Ruiqi Zhang, Ying Li, Wenya Wang, Zixian Sun, Lushuai Zhou, Zhiyu Ni, Nan Zhang, Yu Guo. Discovery and structural investigation of Varicella-Zoster virus gE-neutralizing antibodies isolated from a convalescent patient. Protein Cell, 2025, 16(12): 1054-1059 DOI:10.1093/procel/pwaf051

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cao Y , Su B , Guo X et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B Cells. Cell 2020; 182: 73- 84.e16.

[2]	Duchon JM , Levin MJ , Gershon AA . Safety and varicella outcomes in in utero-exposed newborns and preterm infants treated with Varicella Zoster Immune Globulin(VARIZIG): a subgroup analysis of an expanded-access program. J Pediatric Infect Dis Soc 2020; 9: 449- 453.

[3]	Fowler WJ , Garcia-Valcarcel M , Hill-Perkins MS et al. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicellazoster virus. Virology 1995; 214: 531- 540.

[4]	Gans H , Chemaly RF . Varicella zoster immune globulin(human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. BMC Infect Dis 2021; 21: 46.

[5]	Garcia-Valcarcel M , Fowler WJ , Harper DR et al. Induction of neutralizing antibody and T-cell responses to varicellazoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE). Vaccine 1997; 15: 709- 719.

[6]	Gershon AA , Breuer J , Cohen JI et al. Varicella zoster virus infection. Nat Rev Dis Primers 2015; 1: 15016.

[7]	Guo Y , Zhang G , Yang Q et al. Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. Nat Commun 2023; 14: 3537.

[8]	Harshbarger WD , Holzapfel G , Seraj N et al. Structures of the Varicella Zoster virus glycoprotein e and epitope mapping of vaccine-elicited antibodies. Vaccines (Basel) 2024; 12: 1111.

[9]	Johnson RW , Rice AS . Clinical practice. Postherpetic neuralgia. N Engl J Med 2014; 371: 1526- 1533.

[10]	Oliver SL , Xing Y , Chen DH et al. A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation. Nat Commun 2020; 11: 4141.

[11]	Sullivan NL , Reuter-Monslow MA , Sei J et al. Breadth and functionality of varicella-zoster virus glycoproteinspecific antibodies identified after Zostavax vaccination in humans. J Virol 2018; 92: e00269- 18.

[12]	Wang N , Zhao D , Wang J et al. Architecture of African swine fever virus and implications for viral assembly. Science 2019; 366: 640- 644.

[13]	Zerboni L , Berarducci B , Rajamani J et al. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis. J Virol 2011; 85: 98- 111.

[14]	Zerboni L , Sen N , Oliver SL et al. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 2014; 12: 197- 210.

[15]	Zhu R , Liu J , Chen C et al. A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice. Vaccine 2016; 34: 1589- 1596.